Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Atypon full text link Atypon Free PMC article
Full text links

Actions

Review
.2021 Jan 1;14(1):1875601.
doi: 10.1080/16549716.2021.1875601.

COVID-19 in Germany and China: mitigation versus elimination strategy

Affiliations
Review

COVID-19 in Germany and China: mitigation versus elimination strategy

Guangyu Lu et al. Glob Health Action..

Abstract

Background: The COVID-19 pandemic shows variable dynamics in WHO Regions, with lowest disease burden in the Western-Pacific Region. While China has been able to rapidly eliminate transmission of SARS-CoV-2, Germany - as well as most of Europe and the Americas - is struggling with high numbers of cases and deaths.Objective: We analyse COVID-19 epidemiology and control strategies in China and in Germany, two countries which have chosen profoundly different approaches to deal with the epidemic.Methods: In this narrative review, we searched the literature from 1 December 2019, to 4 December 2020.Results: China and several neighbours (e.g. Australia, Japan, South Korea, New Zealand, Thailand) have achieved COVID-19 elimination or sustained low case numbers. This can be attributed to: (1) experience with previous coronavirus outbreaks; (2) classification of SARS-CoV-2 in the highest risk category and consequent early employment of aggressive control measures; (3) mandatory isolation of cases and contacts in institutions; (4) broad employment of modern contact tracking technology; (5) travel restrictions to prevent SARS-CoV-2 re-importation; (6) cohesive communities with varying levels of social control.Conclusions: Early implementation of intense and sustained control measures is key to achieving a near normal social and economic life.

Keywords: COVID-19; China; Germany; health policy; pandemic.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests.

Figures

Figure 1.
Figure 1.
Number of COVID-19 cases reported weekly by WHO Region, 30 December 2019 through 13 December 2020
Figure 2.
Figure 2.
Number of COVID-19 deaths reported weekly by WHO Region, 30 December 2019 through 13 December 2020
Figure 3.
Figure 3.
COVID-19 control interventions in China and number of laboratory-confirmed cases from 20 January to 20 December 2020
Figure 4.
Figure 4.
Covid-19 control interventions in Germany and number of laboratory-confirmed cases and deaths from 28 January to 20 December 2020
See this image and copyright information in PMC

References

    1. de Wit E, van Doremalen N, Falzarano D, et al. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–11. Epub 2016/ 06/28. - PMC - PubMed
    1. Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2020. Epub 2020/ 10/08. DOI: 10.1038/s41579-020-00459-7 - DOI - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. Epub 2020/ 01/25. - PMC - PubMed
    1. Muller O, Neuhann F, Razum O.. Epidemiology and control of COVID-19. Dtsch Med Wochenschr. 2020;145:670–674. Epub 2020/ 04/29. - PMC - PubMed
    1. John Hopkins University . Covid-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2020. [cited 2020 Dec 10]. Avaiable from:https://publichealthupdate.com/jhu/

Publication types

MeSH terms

LinkOut - more resources

Full text links
Atypon full text link Atypon Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp